Cite
MLA Citation
Michael J. Hanley et al.. “A Phase 1 Drug‐Drug Interaction Study Between Brigatinib and the CYP3A Substrate Midazolam in Patients With ALK‐Positive or ROS1‐Positive Solid Tumors.” Journal of clinical pharmacology, vol. 63, 2023, pp. 583–592. http://access.bl.uk/ark:/81055/vdc_100184054710.0x000052